Logo image of ECDA

ECD AUTOMOTIVE DESIGN INC (ECDA) Stock Fundamental Analysis

NASDAQ:ECDA - Nasdaq - US27877D1046 - Common Stock - Currency: USD

0.27  -0.03 (-10%)

Fundamental Rating

1

Taking everything into account, ECDA scores 1 out of 10 in our fundamental rating. ECDA was compared to 38 industry peers in the Automobiles industry. Both the profitability and financial health of ECDA have multiple concerns. ECDA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ECDA had negative earnings in the past year.
ECDA had a negative operating cash flow in the past year.
ECDA Yearly Net Income VS EBIT VS OCF VS FCFECDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -45.94%, ECDA is doing worse than 73.68% of the companies in the same industry.
Industry RankSector Rank
ROA -45.94%
ROE N/A
ROIC N/A
ROA(3y)-20.98%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ECDA Yearly ROA, ROE, ROICECDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

ECDA has a better Gross Margin (26.30%) than 89.47% of its industry peers.
The Profit Margin and Operating Margin are not available for ECDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ECDA Yearly Profit, Operating, Gross MarginsECDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 -40

1

2. Health

2.1 Basic Checks

ECDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
ECDA has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, ECDA has a worse debt to assets ratio.
ECDA Yearly Shares OutstandingECDA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
ECDA Yearly Total Debt VS Total AssetsECDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -0.83, we must say that ECDA is in the distress zone and has some risk of bankruptcy.
ECDA has a Altman-Z score of -0.83. This is comparable to the rest of the industry: ECDA outperforms 44.74% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.83
ROIC/WACCN/A
WACC13.3%
ECDA Yearly LT Debt VS Equity VS FCFECDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

A Current Ratio of 0.68 indicates that ECDA may have some problems paying its short term obligations.
ECDA has a Current ratio of 0.68. This is in the lower half of the industry: ECDA underperforms 68.42% of its industry peers.
ECDA has a Quick Ratio of 0.68. This is a bad value and indicates that ECDA is not financially healthy enough and could expect problems in meeting its short term obligations.
ECDA's Quick ratio of 0.09 is on the low side compared to the rest of the industry. ECDA is outperformed by 86.84% of its industry peers.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.09
ECDA Yearly Current Assets VS Current LiabilitesECDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

2

3. Growth

3.1 Past

ECDA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2472.00%.
The Revenue has grown by 29.10% in the past year. This is a very strong growth!
EPS 1Y (TTM)-2472%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-437.65%
Revenue 1Y (TTM)29.1%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-65.08%

3.2 Future

ECDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.43% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y54.55%
EPS Next 2Y89.5%
EPS Next 3Y53.13%
EPS Next 5Y36.43%
Revenue Next Year-9.16%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ECDA Yearly Revenue VS EstimatesECDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 10M 20M 30M
ECDA Yearly EPS VS EstimatesECDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 -0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

ECDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ECDA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ECDA Price Earnings VS Forward Price EarningsECDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECDA Per share dataECDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6 0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as ECDA's earnings are expected to grow with 53.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.5%
EPS Next 3Y53.13%

0

5. Dividend

5.1 Amount

No dividends for ECDA!.
Industry RankSector Rank
Dividend Yield N/A

ECD AUTOMOTIVE DESIGN INC

NASDAQ:ECDA (5/21/2025, 3:07:43 PM)

0.27

-0.03 (-10%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)05-02 2025-05-02
Earnings (Next)N/A N/A
Inst Owners1.63%
Inst Owner Change-22.42%
Ins Owners71.23%
Ins Owner Change0%
Market Cap9.56M
Analysts82.86
Price Target5.1 (1788.89%)
Short Float %1.19%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-37.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)37.5%
EPS NY rev (3m)-1100%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-28.45%
Revenue NY rev (3m)-34.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.82
BVpS-0.54
TBVpS-0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.94%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.3%
FCFM N/A
ROA(3y)-20.98%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.91%
Cap/Sales 0.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.09
Altman-Z -0.83
F-Score2
WACC13.3%
ROIC/WACCN/A
Cap/Depr(3y)239.21%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2472%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-437.65%
EPS Next Y54.55%
EPS Next 2Y89.5%
EPS Next 3Y53.13%
EPS Next 5Y36.43%
Revenue 1Y (TTM)29.1%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-65.08%
Revenue Next Year-9.16%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-196.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-292.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-389.16%
OCF growth 3YN/A
OCF growth 5YN/A